Search Results - "Hartig, G.K"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Imatinib plus Cetuximab as a Window of Opportunity Clinical Trial in Head and Neck Cancer by Bruce, J.Y., Glazer, T., Iida, M., Mehall, B., Kostecki, K.L., Yu, M., Wieland, A., Hartig, G.K., McCulloch, T.M., Trask, D., Burr, A., Harari, P.M., Kimple, R.J., Wheeler, D.L.

    “…Cetuximab, an approved anti-EGFR receptor monoclonal antibody, is used for the treatment of metastatic cancer, often in conjunction with cytotoxic…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20